ResearchSpace

Patents and technology transfer in CRISPR technology

Show simple item record

dc.contributor.author Grobler, Lichelle R
dc.contributor.author Suleman, Essa
dc.contributor.author Thimiri Govindaraj, Deepak B
dc.date.accessioned 2021-12-03T09:24:42Z
dc.date.available 2021-12-03T09:24:42Z
dc.date.issued 2021-02
dc.identifier.citation Grobler, L.R., Suleman, E. & Thimiri Govindaraj, D.B. 2021. Patents and technology transfer in CRISPR technology. <i>Progress in Molecular Biology and Translational Science, 180.</i> http://hdl.handle.net/10204/12184 en_ZA
dc.identifier.issn 1877-1173
dc.identifier.uri DOI: 10.1016/bs.pmbts.2021.01.009
dc.identifier.uri http://hdl.handle.net/10204/12184
dc.description.abstract CRISPR technology has revolutionized biological research in the last decade and many academic institutions and companies have patented CRISPR systems and applications. Several patents have been filed for various applications of CRISPR in different industries such as agriculture, synthetic biology, bio-nanotechnology and precision medicine. Despite tremendous pressure on the technology transfer teams, several startups and spin-out companies are already using CRISPR technologies for commercial applications. In this chapter, we discuss the different CRISPR nucleases and their applications. Secondly, we detail our current opinion and perspective on the CRISPR patent and technology landscape for non-mammalian systems. We present two case-studies on CRISPR diagnostics companies, SHERLOCK and Mammoth Biosciences, who are currently at the forefront of establishing diagnostics platforms for coronavirus (SARS-CoV-2) detection. Finally, our chapter identifies future advancements and possible challenges that CRISPR technology might face in non-mammalian systems. en_US
dc.format Abstract en_US
dc.language.iso en en_US
dc.relation.uri https://www.sciencedirect.com/science/article/abs/pii/S187711732100020X en_US
dc.source Progress in Molecular Biology and Translational Science, 180 en_US
dc.subject CRISPR technology en_US
dc.subject CRISPR patent landscape en_US
dc.subject Mammoth biosciences en_US
dc.subject Non-mammalian system en_US
dc.title Patents and technology transfer in CRISPR technology en_US
dc.type Article en_US
dc.description.pages 153-182 en_US
dc.description.note Copyright: 2021 Elsevier Inc. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website: https://www.sciencedirect.com/science/article/abs/pii/S187711732100020X en_US
dc.description.cluster Next Generation Health en_US
dc.description.impactarea Synthetic Nanobiotech Biomachs en_US
dc.description.impactarea Vetnry Mol Diagnostics and Vac en_US
dc.identifier.apacitation Grobler, L. R., Suleman, E., & Thimiri Govindaraj, D. B. (2021). Patents and technology transfer in CRISPR technology. <i>Progress in Molecular Biology and Translational Science, 180</i>, http://hdl.handle.net/10204/12184 en_ZA
dc.identifier.chicagocitation Grobler, Lichelle R, Essa Suleman, and Deepak B Thimiri Govindaraj "Patents and technology transfer in CRISPR technology." <i>Progress in Molecular Biology and Translational Science, 180</i> (2021) http://hdl.handle.net/10204/12184 en_ZA
dc.identifier.vancouvercitation Grobler LR, Suleman E, Thimiri Govindaraj DB. Patents and technology transfer in CRISPR technology. Progress in Molecular Biology and Translational Science, 180. 2021; http://hdl.handle.net/10204/12184. en_ZA
dc.identifier.ris TY - Article AU - Grobler, Lichelle R AU - Suleman, Essa AU - Thimiri Govindaraj, Deepak B AB - CRISPR technology has revolutionized biological research in the last decade and many academic institutions and companies have patented CRISPR systems and applications. Several patents have been filed for various applications of CRISPR in different industries such as agriculture, synthetic biology, bio-nanotechnology and precision medicine. Despite tremendous pressure on the technology transfer teams, several startups and spin-out companies are already using CRISPR technologies for commercial applications. In this chapter, we discuss the different CRISPR nucleases and their applications. Secondly, we detail our current opinion and perspective on the CRISPR patent and technology landscape for non-mammalian systems. We present two case-studies on CRISPR diagnostics companies, SHERLOCK and Mammoth Biosciences, who are currently at the forefront of establishing diagnostics platforms for coronavirus (SARS-CoV-2) detection. Finally, our chapter identifies future advancements and possible challenges that CRISPR technology might face in non-mammalian systems. DA - 2021-02 DB - ResearchSpace DP - CSIR J1 - Progress in Molecular Biology and Translational Science, 180 KW - CRISPR technology KW - CRISPR patent landscape KW - Mammoth biosciences KW - Non-mammalian system LK - https://researchspace.csir.co.za PY - 2021 SM - 1877-1173 T1 - Patents and technology transfer in CRISPR technology TI - Patents and technology transfer in CRISPR technology UR - http://hdl.handle.net/10204/12184 ER - en_ZA
dc.identifier.worklist 25002 en_US


Files in this item

Thumbnail
Name: Grobler_2021_Abst ...
Size: 103.5Kb
Format: PDF
Description: Abstract
View/Open

This item appears in the following Collection(s)

Show simple item record